A New Jersey appeals court has overturned two verdicts totaling $83 million in suits against Johnson & Johnson and C.R. Bard over alleged defects in the companies’ vaginal mesh products.

In separate trials before two judges, evidentiary rulings wrongly excluded evidence that the companies’ products received a designation known as Section 510(K) clearance from the Food and Drug Administration, the appeals court said.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]